Intravenous Iron in Colorectal Cancer Surgery

Seminars in Hematology

Volumn 43, Issue SUPPL. 6, 2006, Pages

  Munoz, Manuel ^a   Campos, Arturo ^b   García Erce, José Antonio ^c  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRIC HYDROXIDE SUCROSE; IRON;

ANEMIA; ARTICLE; BLOOD AUTOTRANSFUSION; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; ERYTHROCYTE TRANSFUSION; HUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 33749241748     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2006.08.005     Document Type: Article

References (21)

1. Sadahiro S., Suzuki T., Tokunaga N., Mukai M., Tajima T., Makuuchi H., et al. Anemia in patients with colorectal cancer. J Gastroenterol 33 (1998) 488-494
2. Beale A.L., Penney M.D., and Allison M.C. The prevalence of iron deficiency among patients presenting with colorectal cancer. Colorectal Dis 7 (2005) 398-402
3. Prutki M., Poljak-Blazi M., Jakopovic M., Tomas D., Stipancic I., and Zarkovic N. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Lett 238 (2006) 188-196
4. Li F., Kishida T., and Kobayashi M. Serum iron and ferritin levels in patients with colorectal cancer in relation to the size, site, and disease stage of cancer. J Gastroenterol 34 (1999) 195-199
5. Jensen L.S., Puho E., Pedersen L., Mortensen F.V., and Sorensen H.T. Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: A follow-up study. Lancet 365 (2005) 681-682
6. Vamvakas E.C., and Carven J.H. Allogeneic blood transfusion, hospital charges, and length of hospitalization: A study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 122 (1998) 145-151
7. Okuyama M., Ikeda K., Shibata T., Tsukahara Y., Kitada M., and Shimano T. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today 35 (2005) 36-40
8. Campos A., Sevilla I., Baca J.J., Romero A., Ramírez G., and Muñoz M. Perioperative iron therapy and transfusion requirements in patients undergoing surgery for colon cancer. Preliminary results. Transfusion Alternatives Transfusion Med 7 suppl (2005) 96 (abstr)
9. Christodoulakis M., Tsiftsis D.D., and Hellenic Surgical Oncology Perioperative EPO Study Group. Preoperative epoetin alfa in colorectal surgery: A randomized, controlled study. Ann Surg Oncol 12 (2005) 718-725
10. Kettelhack C., Hones C., Messinger D., and Schlag P.M. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 85 (1998) 63-67
11. Qvist N., Boesby S., Wolff B., and Hansen C.P. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: Reduced need for blood transfusions in patients undergoing colorectal surgery-Prospective double-blind placebo-controlled study. World J Surg 23 (1999) 30-35
12. Braga M., Gianotti L., Gentilini O., Vignali A., and Di Carlo V. Erythropietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery. Hepatogastroenterology 44 (1997) 685-690
13. Kosmadakis N., Messaris E., Maris A., Katsaragakis S., Leandros E., Konstadoulakis M.M., et al. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg 237 (2003) 417-421
14. Tsuji Y., Kambayashi J., Shiba E., Sakon M., Kawasaki T., and Mori T. Effect of recombinant human erythropoietin on anaemia after gastrectomy: A pilot study. Eur J Surg 161 (1995) 29-33
15. Heiss M.M., Tarabichi A., Delanoff C., Allgayer H., Jauch K.W., Hernandez-Richter T., et al. Perisurgical erythropoietin application in anemic patients with colorectal cancer: A double-blind randomized study. Surgery 119 (1996) 523-527
16. Hoynck van Papendrecht M.A., Hop W., Langenhorst B.L., Kothe F.C., Marquet R.L., and Jeekel J. Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: Results from a randomized clinical study. Vox Sang 62 (1992) 102-107
17. Heiss M.M., Mempel W., Jauch K.W., Delanoff C., Mayer G., Mempel M., et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 342 (1993) 1328-1333
18. Busch O.R., Hop W.C., Hoynck van Papendrecht M.A., Marquet R.L., and Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328 (1993) 1372-1376
19. Vignali A., Braga M., Dionigi P., Radaelli G., Gentilini O., Bellini A., et al. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer. Eur J Surg 161 (1995) 487-492
20. Braga M., Gianotti L., Vignali A., Gentilini O., Servida P., Bordignon C., et al. Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract. Br J Surg 82 (1995) 1637-1640
21. Rau B., Schlag P.M., Willeke F., Herfarth C., Stephan P., and Franke W. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO). Eur J Cancer 34 (1998) 992-998